Cizumab is a DGCI-approved Bevacizumab biosimilar injection used in the treatment of colorectal, rectal, ovarian, kidney, cervical, lung, and brain tumors. bevacizumab 400 mg, bevacizumab side effects, bevacizumab dose, bevacizumab uses, bevacizumab mechanism of action, Bevacizumab Biosimilar Injection, Cervical Cancer Treatment, Ovarian Cancer Treatment, Colon and Rectum Cancer Treat... https://www.cizumab.com/